HSBC HOLDINGS PLC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$45,534,000
-0.0%
386,006
-0.0%
0.05%
-11.5%
Q4 2020$45,535,000
+54.2%
386,021
+45.4%
0.06%
+29.8%
Q3 2020$29,523,000
+7.9%
265,528
-0.8%
0.05%
-9.6%
Q2 2020$27,350,000
-34.7%
267,661
-31.1%
0.05%
-46.4%
Q1 2020$41,903,000
-8.5%
388,272
-1.7%
0.10%
+21.2%
Q4 2019$45,809,000
-54.1%
394,932
-54.7%
0.08%
-57.0%
Q3 2019$99,783,000
-5.4%
871,697
-21.2%
0.19%
-7.0%
Q2 2019$105,463,000
-19.4%
1,106,636
-22.8%
0.20%
-16.3%
Q1 2019$130,817,000
+22.0%
1,433,611
+1.5%
0.24%
+20.7%
Q4 2018$107,191,000
-9.8%
1,412,488
-4.9%
0.20%
+3.7%
Q3 2018$118,785,000
+69.8%
1,484,839
+110.8%
0.19%
+52.8%
Q2 2018$69,966,000
+26.9%
704,384
+3.4%
0.12%
+52.4%
Q1 2018$55,155,000
+10.2%
680,936
+7.2%
0.08%
+13.9%
Q4 2017$50,048,000
+1158.1%
635,372
+1373.4%
0.07%
+1100.0%
Q3 2017$3,978,00043,1230.01%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q4 2020
NameSharesValueWeighting ↓
Maso Capital Partners Ltd 143,300$11,464,00011.16%
Hillhouse Capital Management 2,751,200$220,096,0005.88%
York Capital Management Global Advisors, LLC 1,167,643$93,411,0002.95%
Kite Lake Capital Management (UK) LLP 152,836$12,227,0002.53%
RUDMAN ERROL M 80,000$6,400,0002.39%
Dalton Investments, Inc. 54,551$4,364,0002.04%
Greenwoods Asset Management Ltd 245,000$19,600,0001.91%
Point72 Hong Kong Ltd 47,296$3,784,0001.29%
Temasek Holdings (Private) Ltd 990,000$79,200,0000.46%
Kassirer Asset Management Corp 6,000$480,0000.32%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders